John Delaney

Executive Director, Research
Amgen
Stefan Geschwindner
John joined Amgen in 1992 serving in various roles across the Protein Science and Biologics function, and most recently leading Amgens Biologic Discovery function responsible for identifying large molecule therapeutic candidates in collaboration with all Amgen Therapeutic Areas. From 2010 through 2019, John was the Site Head for Amgens Burnaby, British Columbia research facility, managing the companys significant protein science resources in Canada, and overseeing site administration. John has a new unique role in Amgen Research, being responsible technology and innovation prospecting while developing, growing, and encouraging collaborations across the spectrum of Research disciplines. John holds a Bachelor of Science in Zoology from the University of Montana and earned his Ph.D. in the Department of Microbiology at the University of Arizona under the guidance of Dr. Harris Bernstein. He completed his postdoctoral training at the University of Utahs Department of Cellular, Viral, and Molecular Biology working on the molecular biology of chaperones and bacterial thermotolerance.

Sessions

No data was found

Other Speakers

Download Brochure

Full details regarding the R&D Series are available for download in the Conference Brochure